Literature DB >> 3357776

The adenovirus tripartite leader sequence can alter nuclear and cytoplasmic metabolism of a non-adenovirus mRNA within infected cells.

M A Moore1, T Shenk.   

Abstract

All mRNAs encoded by the adenovirus major late transcription unit share a common 5' noncoding region, 200 nucleotides in length, termed the tripartite leader sequence. To assess function of the tripartite leader, recombinant viruses were prepared which carried either a bona fide herpes simplex virus thymidine kinase gene or a modified thymidine kinase gene whose normal 5' noncoding domain was replaced with the adenovirus leader sequence. The tripartite leader simultaneously decreased the nuclear half-life and increased the cytoplasmic half-life of the thymidine kinase-specific mRNA. The tripartite leader stabilized the non-adenovirus mRNA only within the environment of an adenovirus-infected cell during the late phase of the infectious cycle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357776      PMCID: PMC338213          DOI: 10.1093/nar/16.5.2247

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Adenovirus-2 messengers--an example of baroque molecular architecture.

Authors:  T R Broker; L T Chow; A R Dunn; R E Gelinas; J A Hassell; D F Klessig; J B Lewis; R J Roberts; B S Zain
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

2.  Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA.

Authors:  S Zain; J Sambrook; R J Roberts; W Keller; M Fried; A R Dunn
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  High stability of messenger RNA in growing cultured cells.

Authors:  J R Greenberg
Journal:  Nature       Date:  1972-11-10       Impact factor: 49.962

4.  Transcriptional regulation of hemoglobin switching in chicken embryos.

Authors:  M Groudine; M Peretz; H Weintraub
Journal:  Mol Cell Biol       Date:  1981-03       Impact factor: 4.272

5.  Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus.

Authors:  J R Smiley
Journal:  Nature       Date:  1980-05-29       Impact factor: 49.962

6.  Transcriptional regulation of the ovalbumin and conalbumin genes by steroid hormones in chick oviduct.

Authors:  G S McKnight; R D Palmiter
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

7.  Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12.

Authors:  F Colbere-Garapin; S Chousterman; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

8.  Physical mapping of a large-plaque mutation of adenovirus type 2.

Authors:  G Chinnadurai; S Chinnadurai; J Brusca
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

9.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  4 in total

1.  Adenovirus early region 4 stimulates mRNA accumulation via 5' introns.

Authors:  K Nordqvist; G Akusjärvi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.

Authors:  W Huang; S J Flint
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 3.  mRNA stability in mammalian cells.

Authors:  J Ross
Journal:  Microbiol Rev       Date:  1995-09

4.  Adenovirus vector expressing functional herpes simplex virus ICP0.

Authors:  X X Zhu; C S Young; S Silverstein
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.